Home » Newsletters » BioWorld Science

BioWorld Science

March 7, 2000

View Archived Issues

Merck returns alpha-adrenergic technology rights to Synaptic

Squalamine enters combination trials with cisplatin for advanced cancer

Novo Nordisk and Schering-Plough conclude diabetes copromotion agreement

Structure elucidation, biological activity of a novel antimitotic agent: FR-182877

Potent histamine H3 receptor ligands designed at Sanofi-Synthelabo

New Lilly compounds potentiate glutamate receptor function

Macrophage scavenger receptor antagonists under study at SB

Modulators of CCR5 receptor and their use presented by SmithKline Beecham

New epipodophyllotoxin anticancer agent reported; studies on mechanism of action described

Daiichi claims pyrazole derivatives as antitumor agents

N-type calcium channel antagonists in early development at Ono

Aventis responds to the need for new antibiotics: first regulatory filing for the ketolide class

European mutual recognition approval obtained for candesartan/HCTZ combination

Ilex Oncology acquires U.S. operations of British Biotech

Patent covering novel HCV discovery issued to Chiron

Tyrosine kinase inhibitor D-58 is a potent antiallergic, antiinflammatory agent

AAAAI news: BM-144 as a new lead TxA2 antagonist molecule for asthma, thrombosis

DP-b99 enters phase I testing in Germany

Peptidomimetic VLA-4 antagonists: promising early results presented at AAAAI meeting

Amerimmune's phase I/II trial of Cytolin now formally under way

Elan to enter the oncology market by acquiring The Liposome Company

Heparinase-inhibitory fungal metabolites discovered by Korean/Japanese research team

Aerosol route preferred for measles vaccination campaign

New use patents expand coverage for Aradigm's pulmonary drug delivery system

Use of secretin for autism receives broad patent coverage

Gelkem and Ethypharm to jointly develop controlled-release drugs

Thalamic stimulation provides benefits over thalamotomy for severe tremor

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...